FR16M - New drug in particular for the treatment of inflammatory phenomena of rheumatic, arthritic or hepatic origin. - Google Patents

New drug in particular for the treatment of inflammatory phenomena of rheumatic, arthritic or hepatic origin.

Info

Publication number
FR16M
FR16M FR831770A FR831770A FR16M FR 16 M FR16 M FR 16M FR 831770 A FR831770 A FR 831770A FR 831770 A FR831770 A FR 831770A FR 16 M FR16 M FR 16M
Authority
FR
France
Prior art keywords
arthritic
rheumatic
treatment
new drug
inflammatory phenomena
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR831770A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Francais de Chimiotherapie SA
Original Assignee
Laboratoires Francais de Chimiotherapie SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR827205A external-priority patent/FR1363860A/en
Application filed by Laboratoires Francais de Chimiotherapie SA filed Critical Laboratoires Francais de Chimiotherapie SA
Priority to FR831770A priority Critical patent/FR16M/en
Application granted granted Critical
Publication of FR16M publication Critical patent/FR16M/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06—Benzopyran radicals
    • C07H17/065—Benzo[b]pyrans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06—Benzopyran radicals
    • C07H17/065—Benzo[b]pyrans
    • C07H17/07—Benzo[b]pyran-4-ones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
FR831770A 1960-05-14 1960-07-01 New drug in particular for the treatment of inflammatory phenomena of rheumatic, arthritic or hepatic origin. Expired FR16M (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR831770A FR16M (en) 1960-05-14 1960-07-01 New drug in particular for the treatment of inflammatory phenomena of rheumatic, arthritic or hepatic origin.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR827205A FR1363860A (en) 1960-05-14 1960-05-14 New corticosteroids and their preparation process
FR831770A FR16M (en) 1960-05-14 1960-07-01 New drug in particular for the treatment of inflammatory phenomena of rheumatic, arthritic or hepatic origin.

Publications (1)

Publication Number Publication Date
FR16M true FR16M (en) 1961-01-06

Family

ID=39811722

Family Applications (1)

Application Number Title Priority Date Filing Date
FR831770A Expired FR16M (en) 1960-05-14 1960-07-01 New drug in particular for the treatment of inflammatory phenomena of rheumatic, arthritic or hepatic origin.

Country Status (1)

Country Link
FR (1) FR16M (en)

Similar Documents

Publication Publication Date Title
FR37M (en) New drug in particular for the treatment of inflammatory phenomena of rheumatic, arthritic or hepatic origin.
FR3244M (en) New drug in particular for the treatment of inflammatory manifestations of rheumatic, arthritic or infectious origin.
FR1187M (en) New drug in particular for the treatment of inflammatory manifestations of arthritic or infectious rheumatic origin.
FR126M (en) New drug, in particular for the treatment of postprandial or chronic hyperlipemia.
FR16M (en) New drug in particular for the treatment of inflammatory phenomena of rheumatic, arthritic or hepatic origin.
FR1438M (en) New drug effective in the treatment of atherosclerosis.
FR3316M (en) New drug in particular for the treatment of inflammatory manifestations of rheumatic, arthritic or infectious origin.
FR342M (en) New tri-hydroxylated steroid drug, in particular for the treatment of spasms of coronary origin.
FR151M (en) New drug, in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR186M (en) New drug in particular for the treatment of inflammatory reactions of toxic or infectious rheumatic origin.
BE612141Q (en) New drugs in particular for the treatment of spasms of coronary origin.
FR2929M (en) Pharmaceutical composition for the treatment of arthritic and rheumatic conditions.
BE598672A (en) Therapeutic composition for the treatment of hepatic disorders.
FR139M (en) New drug for the treatment of migraines of hepatic origin and in general hepatic disorders.
FR1484M (en) New drug in particular for the treatment of inflammatory manifestations of microbial origin.
FR1783M (en) Stabilized forms of dimethylcarboxy-alkylsulfonium used, in particular, for the treatment of hepatic and vascular disorders.
FR3419M (en) New drugs, in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR1764M (en) New drug in particular for the treatment of spasms of coronary or visceral origin.
FR1804M (en) New drug in particular for the treatment of infections of microbial origin.
FR153M (en) New isopropylated drug, in particular for the treatment of neurodepressive states and anxiety psychoses.
FR385M (en) New drug for the treatment of staphylococcal infections and the like.
FR2603M (en) New drug in particular for the treatment of hepatic degenerations of chemical, bacterial, toxic or senile origin.
FR1635M (en) New drug in particular for the treatment of spasms of coronary origin.
FR1141M (en) New drug in particular for the treatment of spasms of coronary origin.
FR133M (en) New dihydroxy drug, in particular for the treatment of spasms of coronary origin.